Biology:Epoetin theta
| Clinical data | |
|---|---|
| Trade names | Biopoin, Eporatio |
| License data | |
| ATC code |
|
| Legal status | |
| Legal status | |
Epoetin theta, sold under the brand name Biopoin among others, is a copy of the human hormone erythropoietin.[1][2]
The most common side effects include shunt thrombosis (clots that can form in blood vessels of patients on dialysis, a blood clearance technique), headache, hypertension (high blood pressure), hypertensive crisis (sudden, dangerously high blood pressure), skin reactions, arthralgia (joint pain) and influenza (flu)-like illness.[1]Epoetin theta was approved for medical use in the European Union in October 2009.[1] It is on the World Health Organization's List of Essential Medicines.[3]
Medical uses
Epoetin theta is indicated for the treatment of symptomatic anemia in adults.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Biopoin EPAR". https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ↑ 2.0 2.1 "Eporatio EPAR". https://www.ema.europa.eu/en/medicines/human/EPAR/eporatio. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ↑ World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. WHO/MHP/HPS/EML/2021.02.
attribution contains material copied from Biopoin | European Medicines Agency https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin 2021
External links
- "Epoetin theta". Drug Information Portal. U.S. National Library of Medicine. https://druginfo.nlm.nih.gov/drugportal/rn/762263-14-9.
 |  |
